Vascular Biogenics - 48 Year Dividend History | VBLT

Historical dividend payout and yield for Vascular Biogenics (VBLT) since 1971. The current TTM dividend payout for Vascular Biogenics (VBLT) as of June 14, 2019 is $0.00. The current dividend yield for Vascular Biogenics as of June 14, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.043B $0.001B
Vascular Biogenics Ltd. is a clinical stage biotechnology company. It is focused on the discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead oncology candidate VB-111, is a gene-based biologic which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer. It is also developing VB-201, an oral small molecule that is in Phase II clinical trials for the treatment psoriasis and ulcerative colitis. Vascular Biogenics Ltd. is headquartered in Or Yehuda, Israel.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.398B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83